Aspirin-Exacerbated Respiratory Disease Polymorphisms; a review study

Gene. 2023 Jun 20:870:147326. doi: 10.1016/j.gene.2023.147326. Epub 2023 Apr 1.

Abstract

Aspirin exacerbated respiratory disease (AERD) is a condition caused by increased bronchoconstriction in people with asthma after taking aspirin or another NSAID. Molecular analysis of the human genome has opened up new perspectives on human polymorphisms and disease. This study was conducted to identify the genetic factors that influence this disease due to its unknown genetic factors. We evaluated research studies, letters, comments, editorials, eBooks, and reviews. PubMed/MEDLINE, Web of Sciences, Cochrane Library, and Scopus were searched for information. We used the keywords polymorphisms, aspirin-exacerbated respiratory disease, asthma, allergy as search terms. This study included 38 studies. AERD complications were associated with polymorphisms in ALOX15, EP2, ADRB2, SLC6A12, CCR3, CRTH2, CysLTs, DPCR1, DPP10, FPR2, HSP70, IL8, IL1B, IL5RA, IL-13, IL17RA, ILVBL, TBXA2R, TLR3, HLA-DRB and HLA-DQ, HLA-DR7, HLA-DP. AERD was associated with heterogeneity in gene polymorphisms, making it difficult to pinpoint specific gene changes. Therefore, diagnosing and treating AERD may be facilitated by examining common variants involving the disease.

Keywords: Allergy; Aspirin-Exacerbated Respiratory Disease; Asthma; Polymorphisms.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin / adverse effects
  • Asthma*
  • Asthma, Aspirin-Induced* / genetics
  • Humans
  • Polymorphism, Genetic

Substances

  • Aspirin
  • Anti-Inflammatory Agents, Non-Steroidal